Fundraising Fox
/Companies
Sign in

Cognoptix

Boston, US · 3 known investors

Find your way into Cognoptix

Sign up to see every warm intro you have to Cognoptix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cognoptix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.

BiotechDigital HealthMedical Devices

Founders & leadership

DL
Dr. Lee GoldsteinCo-founder
DL
Dr. Leo ChylackCo-founder
SWSusanne Wilke
Susanne WilkePresident & CEOSusanne Wilke is President and CEO of Cognoptix, which develops diagnostic devices for early detection of Alzheimer's disease, and previously served in leadership roles at other biotechnology companies including Neurotrope.
CH
Carl H. SadowskyChief Medical OfficerCarl Sadowsky is Chief Medical Officer at Cognoptix and has led clinical trials in Alzheimer's disease research since 2010, including studies on amyloid biomarkers and multiple approved AD therapeutics. He holds an MD from Weill Medical College of Cornell University, completed neurology and internal medicine residencies at Dartmouth-Hitchcock Medical Center, and previously served as Chief of Neurology at the U.S. Air Force Hospital in Wiesbaden, Germany.
MK
Mike KaswanChief Financial Officer
PHPaul Hartung
Paul HartungChairman, President & CEO2004–2015Paul Hartung is Chairman, President and CEO of Cognoptix, which develops a non-invasive laser eye scanning system for early detection of Alzheimer's disease. He holds an MS in Mechanical Engineering from MIT and has held executive roles in the medical device and technology sectors at companies including GE, 3Com, and Motorola, as well as founding roles at Summit and Winphoria.
TT
Tom TrometerExecutive
GD
Gerald D. CagleExecutive

Board

GW
Gunnar WeikertBoard director
WS
Werner SchaeferBoard director
RG
Richard GillBoard director

Investors · 3

Boston Harbor Angelslisted by Boston Harbor AngelsBoston · $250K – $1.5M

How we know: Boston Harbor Angels's portfolio page · Not right? Tell us

Launchpad Venture GroupreportedBoston · $8M – $10M

How we know: funding news · press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$13M disclosed across 2 rounds · 2014

▶$12.6MraisedOct 2014 · 32 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christine de los ReyesDirector
  • Tom TrometerExecutive Officer
  • Paul HartungExecutive Officer, Director
  • Gunnar WeikertDirector
Offering amount
$15.6M
Amount sold
$12.6M
Sales commissions
$405K
Placement agents
Robert W. Baird & Co. Incorporated
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$390KraisedApr 2014 · 22 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul HartungExecutive Officer, Director
  • Gunnar WeikertDirector
  • Tom TrometerExecutive Officer
  • Gerald D. CagleExecutive Officer
  • Werner SchaeferDirector
  • Richard GillDirector
Offering amount
$1.5M
Amount sold
$390K
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Cognoptix Revitalizes, Appoints New Chief Executive Officer Dr. Susanne Wilke, PhD, Raises Oversubscribed $2.6m Series Rprnewswire.com · Sep 2020

Frequently asked questions

What does Cognoptix do?
Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.
Who founded Cognoptix?
Cognoptix was founded by Dr. Lee Goldstein, Dr. Leo Chylack.
Who are Cognoptix's investors?
Cognoptix's investors include AEON Foundry, Boston Harbor Angels, Launchpad Venture Group.
How much funding has Cognoptix raised?
Cognoptix has disclosed $13M raised across 2 rounds.
Where is Cognoptix headquartered?
Cognoptix is headquartered in Boston, US.